Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and the Emerging Role of Resmetirom: A Comprehensive Review. JIMC. 2025;8(1). Accessed February 3, 2026. https://jimc.org.pk/index.php/jimc/article/view/75